Hind Mrabti

5PUBLICATIONS
16CO-AUTHORS
Predictive and prognostic markersCancer therapy (excl. chemotherapy and radiation therapy)Molecular targetsCancer diagnosisCancer genetics
Featured researcher

Get your video featured.

JoVEPublish with JoVE
Journal

Publications (5)

|Jun 04, 2026
Post-neoadjuvant and peri-operative ctDNA-defined minimal residual disease in triple-negative breast cancer: a systematic review and meta-analysis.

|Feb 27, 2025
Clinical Characteristics of Toxicities of Immune Checkpoint Inhibitors and Their Impact on Efficacy in Solid Cancers: An Analysis of Real-World Data in Moroccan Patients.

Badiaa Batlamous, Sihame Lkhoyaali, Loubna Omri

|Sep 20, 2024
Tackling Predatory Journals in Oncology: Training Is Key!

Salma Najem, Hind Mrabti, Hassan Errihani

|Jul 06, 2022
The first Middle East and North Africa expert consensus recommendations for the management of advanced colorectal cancer.

Hampig R Kourie, Fahad Ibnshamsah, Joseph Zouein

|Jun 26, 2020
Cancer management challenge in a developing country in COVID-19 pandemic: reflection of a group of Moroccan oncologists.

Hind Mrabti, Narjiss Berrada, Ghislaine Raiss

Pageof 1

Frequent Collaborators

1 joint publications

Narjiss Berrada

1 joint publications

Ghislaine Raiss

1 joint publications

Hamza Ettahri

1 joint publications

Halima Abahssain